NJ assembly moves to restrict Botox in minors; China needs better AIDS drug strategy;

@FiercePharma: Cancer drug spending to leap at least 34%. Article | Follow @FiercePharma

> Minors in New Jersey won't be able to get Botox injections without a doctor saying it's medically necessary under a bill moving through the state Assembly. News

> China needs to identify and provide effective AIDS drugs to more HIV patients infected through sexual contact and use of dirty needles if it wants cut HIV death rates and avoid broader transmission of the virus, researchers said. Story

> Drug development firm Merrion Pharmaceuticals has appointed Jonathan O'Connell as its new chief executive officer. He replaces John Lynch. Article

> Sanofi Pasteur named Damian Braga global head of commercial operations; previously, he was president of Sanofi Pasteur U.S. and VP for the Americas. Report

> Alkermes widened its loss in fiscal year, which ended March 31, 2011, over the previous year due to increased costs. News

> AstraZeneca said that it purchased for cancellation 134,897 ordinary shares of AstraZeneca PLC at a price of 3190 pence per share on May 19. Item

Biotech News

@FierceBiotech: ASCO abstracts flag new data on the hottest cancer drugs. Report | Follow @FierceBiotech

@JohnCFierce: Will the FDA really make us wait until Monday for telaprevir OK? | Follow @JohnCFierce

> Hold your breath for Vertex's big telaprevir moment. Story

> ASCO highlights targeted cancer drugs from Pfizer, Exelixis. News

> Epilepsy study results could help Vivus' Qnexa. Item

> EMD Serono chief steps down after MS drug disappointment. Story

> CHMP recommends approval of a host of new drugs. Item 

And Finally... If that's java in your cup, drink up. A new study says that men who are heavy coffee drinkers are at lower risk for prostate cancer. Report

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.